nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Blood pressure systolic increased—Sorafenib—liver cancer	0.277	0.409	CcSEcCtD
Dobutamine—Skin necrosis—Epirubicin—liver cancer	0.0425	0.0627	CcSEcCtD
Dobutamine—Skin necrosis—Doxorubicin—liver cancer	0.0393	0.058	CcSEcCtD
Dobutamine—Skin exfoliation—Sorafenib—liver cancer	0.0383	0.0566	CcSEcCtD
Dobutamine—Hypokalaemia—Sorafenib—liver cancer	0.0265	0.0392	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Epirubicin—liver cancer	0.0164	0.0243	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.0152	0.0225	CcSEcCtD
Dobutamine—Skin exfoliation—Epirubicin—liver cancer	0.0142	0.0209	CcSEcCtD
Dobutamine—Thrombocytopenia—Sorafenib—liver cancer	0.014	0.0207	CcSEcCtD
Dobutamine—Skin exfoliation—Doxorubicin—liver cancer	0.0131	0.0194	CcSEcCtD
Dobutamine—Dyspnoea—Sorafenib—liver cancer	0.0128	0.0189	CcSEcCtD
Dobutamine—Phlebitis—Epirubicin—liver cancer	0.0125	0.0185	CcSEcCtD
Dobutamine—Phlebitis—Doxorubicin—liver cancer	0.0116	0.0171	CcSEcCtD
Dobutamine—Pruritus—Sorafenib—liver cancer	0.0101	0.015	CcSEcCtD
Dobutamine—Hypokalaemia—Epirubicin—liver cancer	0.0098	0.0145	CcSEcCtD
Dobutamine—Hypokalaemia—Doxorubicin—liver cancer	0.00907	0.0134	CcSEcCtD
Dobutamine—Angina pectoris—Epirubicin—liver cancer	0.00907	0.0134	CcSEcCtD
Dobutamine—Headache—Sorafenib—liver cancer	0.00897	0.0133	CcSEcCtD
Dobutamine—Nausea—Sorafenib—liver cancer	0.00851	0.0126	CcSEcCtD
Dobutamine—Angina pectoris—Doxorubicin—liver cancer	0.00839	0.0124	CcSEcCtD
Dobutamine—Palpitations—Epirubicin—liver cancer	0.00573	0.00847	CcSEcCtD
Dobutamine—Chest pain—Epirubicin—liver cancer	0.00552	0.00816	CcSEcCtD
Dobutamine—Palpitations—Doxorubicin—liver cancer	0.0053	0.00784	CcSEcCtD
Dobutamine—Thrombocytopenia—Epirubicin—liver cancer	0.00518	0.00766	CcSEcCtD
Dobutamine—Tachycardia—Epirubicin—liver cancer	0.00517	0.00763	CcSEcCtD
Dobutamine—Chest pain—Doxorubicin—liver cancer	0.00511	0.00755	CcSEcCtD
Dobutamine—Hypotension—Epirubicin—liver cancer	0.00495	0.00731	CcSEcCtD
Dobutamine—Thrombocytopenia—Doxorubicin—liver cancer	0.00479	0.00709	CcSEcCtD
Dobutamine—Tachycardia—Doxorubicin—liver cancer	0.00478	0.00706	CcSEcCtD
Dobutamine—Dyspnoea—Epirubicin—liver cancer	0.00472	0.00697	CcSEcCtD
Dobutamine—Hypotension—Doxorubicin—liver cancer	0.00458	0.00676	CcSEcCtD
Dobutamine—Dyspnoea—Doxorubicin—liver cancer	0.00437	0.00645	CcSEcCtD
Dobutamine—Pruritus—Epirubicin—liver cancer	0.00374	0.00553	CcSEcCtD
Dobutamine—Pruritus—Doxorubicin—liver cancer	0.00346	0.00512	CcSEcCtD
Dobutamine—Headache—Epirubicin—liver cancer	0.00332	0.0049	CcSEcCtD
Dobutamine—Nausea—Epirubicin—liver cancer	0.00314	0.00465	CcSEcCtD
Dobutamine—Headache—Doxorubicin—liver cancer	0.00307	0.00453	CcSEcCtD
Dobutamine—Nausea—Doxorubicin—liver cancer	0.00291	0.0043	CcSEcCtD
Dobutamine—COMT—Neuronal System—BRAF—liver cancer	0.000831	0.00257	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCR4—liver cancer	0.00083	0.00257	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—HPGDS—liver cancer	0.000817	0.00253	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PSMA4—liver cancer	0.00078	0.00241	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PSMD10—liver cancer	0.00078	0.00241	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTA4—liver cancer	0.000779	0.00241	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTA2—liver cancer	0.000759	0.00235	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GOT2—liver cancer	0.000759	0.00235	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CPT1B—liver cancer	0.000753	0.00233	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GLUL—liver cancer	0.000753	0.00233	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTA1—liver cancer	0.000732	0.00227	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PSMD10—liver cancer	0.000729	0.00225	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PSMA4—liver cancer	0.000729	0.00225	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NR1H4—liver cancer	0.000726	0.00225	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NAT2—liver cancer	0.000724	0.00224	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTA3—liver cancer	0.000714	0.00221	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP2E1—liver cancer	0.000714	0.00221	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GOT2—liver cancer	0.000709	0.00219	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALDOB—liver cancer	0.000694	0.00215	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—RAF1—liver cancer	0.000694	0.00215	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYCS—liver cancer	0.000668	0.00207	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP2E1—liver cancer	0.000666	0.00206	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CRABP1—liver cancer	0.000662	0.00205	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GGT1—liver cancer	0.000655	0.00203	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GOT1—liver cancer	0.000655	0.00203	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTA4—liver cancer	0.000653	0.00202	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CHN2—liver cancer	0.000646	0.002	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTA2—liver cancer	0.000636	0.00197	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CHN2—liver cancer	0.000632	0.00195	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYCS—liver cancer	0.000624	0.00193	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTA1—liver cancer	0.000614	0.0019	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GOT1—liver cancer	0.000612	0.00189	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GGT1—liver cancer	0.000612	0.00189	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NAT2—liver cancer	0.000607	0.00188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IFT88—liver cancer	0.000591	0.00183	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GSTP1—liver cancer	0.000589	0.00182	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALDOB—liver cancer	0.000582	0.0018	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—HMOX1—liver cancer	0.000581	0.0018	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HPGDS—liver cancer	0.000579	0.00179	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IFT88—liver cancer	0.000578	0.00179	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CRABP1—liver cancer	0.000555	0.00172	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GSTP1—liver cancer	0.00055	0.0017	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—HMOX1—liver cancer	0.000542	0.00168	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GSTM1—liver cancer	0.000541	0.00167	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PSMA4—liver cancer	0.000516	0.0016	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PSMD10—liver cancer	0.000516	0.0016	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP1A1—liver cancer	0.000513	0.00159	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GSTM1—liver cancer	0.000505	0.00156	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GOT2—liver cancer	0.000502	0.00155	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—TRIO—liver cancer	0.0005	0.00155	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—HRAS—liver cancer	0.000499	0.00154	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—TRIO—liver cancer	0.000489	0.00151	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HPGDS—liver cancer	0.000485	0.0015	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR4—liver cancer	0.000479	0.00148	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP1A1—liver cancer	0.000479	0.00148	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—liver cancer	0.000478	0.00148	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP2E1—liver cancer	0.000472	0.00146	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR4—liver cancer	0.000469	0.00145	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARA—liver cancer	0.000469	0.00145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—TRIO—liver cancer	0.000454	0.0014	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—liver cancer	0.000446	0.00138	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000445	0.00138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—TRIO—liver cancer	0.000444	0.00137	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYCS—liver cancer	0.000442	0.00137	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARA—liver cancer	0.000438	0.00135	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000436	0.00135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR4—liver cancer	0.000435	0.00135	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GGT1—liver cancer	0.000433	0.00134	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GOT1—liver cancer	0.000433	0.00134	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PSMA4—liver cancer	0.000432	0.00134	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PSMD10—liver cancer	0.000432	0.00134	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR4—liver cancer	0.000426	0.00132	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GOT2—liver cancer	0.000421	0.0013	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CG—liver cancer	0.000402	0.00124	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP2E1—liver cancer	0.000396	0.00122	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTP1—liver cancer	0.000389	0.0012	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—liver cancer	0.000388	0.0012	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HMOX1—liver cancer	0.000384	0.00119	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—HRAS—liver cancer	0.000382	0.00118	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CG—liver cancer	0.000375	0.00116	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYCS—liver cancer	0.00037	0.00114	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GGT1—liver cancer	0.000363	0.00112	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GOT1—liver cancer	0.000363	0.00112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SHC3—liver cancer	0.000362	0.00112	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—liver cancer	0.000362	0.00112	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTM1—liver cancer	0.000358	0.00111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SHC3—liver cancer	0.000354	0.0011	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CD—liver cancer	0.000353	0.00109	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ALB—liver cancer	0.000349	0.00108	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—F2—liver cancer	0.000339	0.00105	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP1A1—liver cancer	0.000339	0.00105	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—F2—liver cancer	0.000332	0.00103	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CD—liver cancer	0.00033	0.00102	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTP1—liver cancer	0.000326	0.00101	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ALB—liver cancer	0.000325	0.00101	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—liver cancer	0.000322	0.000995	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—liver cancer	0.000316	0.000978	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARA—liver cancer	0.00031	0.000959	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CB—liver cancer	0.000308	0.000952	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTM1—liver cancer	0.0003	0.000927	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CB—liver cancer	0.000287	0.000889	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP1A1—liver cancer	0.000284	0.000879	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FST—liver cancer	0.000281	0.00087	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCE—liver cancer	0.000276	0.000854	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FST—liver cancer	0.000275	0.000851	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCE—liver cancer	0.00027	0.000835	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TRIO—liver cancer	0.000268	0.00083	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CG—liver cancer	0.000266	0.000822	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—liver cancer	0.000265	0.000819	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TRIO—liver cancer	0.000262	0.000812	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARA—liver cancer	0.00026	0.000804	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR4—liver cancer	0.000257	0.000796	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—liver cancer	0.000256	0.000793	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR4—liver cancer	0.000252	0.000778	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCE—liver cancer	0.000251	0.000775	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCE—liver cancer	0.000245	0.000759	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CSF2—liver cancer	0.000244	0.000755	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CSF2—liver cancer	0.000239	0.000739	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CD—liver cancer	0.000234	0.000722	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—liver cancer	0.000231	0.000713	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CG—liver cancer	0.000223	0.000688	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CSF2—liver cancer	0.000222	0.000686	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CSF2—liver cancer	0.000217	0.000671	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—liver cancer	0.000215	0.000664	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CB—liver cancer	0.000204	0.00063	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADAM17—liver cancer	0.000203	0.000629	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADAM17—liver cancer	0.000199	0.000615	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CD—liver cancer	0.000196	0.000605	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—liver cancer	0.000193	0.000597	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2—liver cancer	0.000192	0.000593	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMA4—liver cancer	0.000191	0.000591	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMD10—liver cancer	0.000191	0.000591	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—liver cancer	0.000188	0.00058	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2—liver cancer	0.000187	0.00058	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMA4—liver cancer	0.000187	0.000578	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMD10—liver cancer	0.000187	0.000578	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—liver cancer	0.000183	0.000567	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—liver cancer	0.000179	0.000555	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—liver cancer	0.000175	0.000542	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2—liver cancer	0.000174	0.000538	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CB—liver cancer	0.000171	0.000528	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2—liver cancer	0.00017	0.000527	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—liver cancer	0.000167	0.000515	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—liver cancer	0.000163	0.000504	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CD—liver cancer	0.000161	0.000499	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CD—liver cancer	0.000158	0.000488	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—liver cancer	0.000153	0.000474	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCE—liver cancer	0.000148	0.000458	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CD—liver cancer	0.000146	0.000453	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCE—liver cancer	0.000145	0.000448	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CD—liver cancer	0.000143	0.000443	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—liver cancer	0.000143	0.000443	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CB—liver cancer	0.000141	0.000435	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—liver cancer	0.00014	0.000434	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CB—liver cancer	0.000137	0.000425	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—liver cancer	0.000137	0.000425	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CSF2—liver cancer	0.000131	0.000405	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RAF1—liver cancer	0.000131	0.000404	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—H2AFX—liver cancer	0.000129	0.000399	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IL2—liver cancer	0.000129	0.000399	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CSF2—liver cancer	0.000128	0.000396	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RAF1—liver cancer	0.000128	0.000396	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CB—liver cancer	0.000128	0.000395	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—H2AFX—liver cancer	0.000126	0.000391	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IL2—liver cancer	0.000126	0.000391	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CB—liver cancer	0.000125	0.000386	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—liver cancer	0.000124	0.000384	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL2—liver cancer	0.000117	0.000363	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—liver cancer	0.000117	0.000361	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL2—liver cancer	0.000115	0.000355	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—liver cancer	0.000114	0.000353	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—liver cancer	0.000107	0.00033	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK14—liver cancer	0.000106	0.000328	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—liver cancer	0.000104	0.000323	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—liver cancer	0.000104	0.000322	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—liver cancer	0.000104	0.000322	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK14—liver cancer	0.000104	0.000321	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2—liver cancer	0.000103	0.000318	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—liver cancer	0.000102	0.000315	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—liver cancer	0.000101	0.000314	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2—liver cancer	0.000101	0.000311	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—liver cancer	9.84e-05	0.000304	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—liver cancer	9.84e-05	0.000304	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—liver cancer	9.63e-05	0.000298	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—liver cancer	9.63e-05	0.000298	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—liver cancer	9.25e-05	0.000286	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—liver cancer	9.05e-05	0.00028	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CD—liver cancer	8.65e-05	0.000268	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—liver cancer	8.57e-05	0.000265	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—liver cancer	8.56e-05	0.000265	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—liver cancer	8.49e-05	0.000263	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—liver cancer	8.47e-05	0.000262	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CD—liver cancer	8.46e-05	0.000262	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—liver cancer	8.38e-05	0.000259	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—liver cancer	8.37e-05	0.000259	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—liver cancer	8.28e-05	0.000256	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—liver cancer	7.78e-05	0.000241	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAF1—liver cancer	7.72e-05	0.000239	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—liver cancer	7.61e-05	0.000235	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAF1—liver cancer	7.55e-05	0.000234	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CB—liver cancer	7.54e-05	0.000233	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MTOR—liver cancer	7.54e-05	0.000233	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CB—liver cancer	7.38e-05	0.000228	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MTOR—liver cancer	7.38e-05	0.000228	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—liver cancer	7.2e-05	0.000223	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1B—liver cancer	7.08e-05	0.000219	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—liver cancer	7.04e-05	0.000218	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—liver cancer	7e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—liver cancer	6.93e-05	0.000214	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL2—liver cancer	6.92e-05	0.000214	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1B—liver cancer	6.92e-05	0.000214	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—liver cancer	6.89e-05	0.000213	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—liver cancer	6.85e-05	0.000212	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—liver cancer	6.78e-05	0.00021	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL2—liver cancer	6.77e-05	0.000209	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—liver cancer	6.75e-05	0.000209	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—liver cancer	6.74e-05	0.000208	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUN—liver cancer	6.74e-05	0.000208	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—liver cancer	6.68e-05	0.000207	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—liver cancer	6.6e-05	0.000204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUN—liver cancer	6.59e-05	0.000204	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—liver cancer	6.55e-05	0.000203	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—liver cancer	6.54e-05	0.000202	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1A—liver cancer	6.53e-05	0.000202	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—liver cancer	6.41e-05	0.000198	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1A—liver cancer	6.39e-05	0.000198	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—liver cancer	6.37e-05	0.000197	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—liver cancer	6.36e-05	0.000197	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—liver cancer	6.23e-05	0.000193	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—liver cancer	6.22e-05	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—liver cancer	5.88e-05	0.000182	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—liver cancer	5.83e-05	0.00018	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—liver cancer	5.76e-05	0.000178	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—liver cancer	5.7e-05	0.000176	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—liver cancer	5.41e-05	0.000167	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—liver cancer	5.4e-05	0.000167	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—liver cancer	5.3e-05	0.000164	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—liver cancer	5.28e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—liver cancer	5e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—liver cancer	4.89e-05	0.000151	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—liver cancer	4.6e-05	0.000142	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—liver cancer	4.5e-05	0.000139	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—liver cancer	4.45e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—liver cancer	4.35e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—liver cancer	4.25e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—liver cancer	4.16e-05	0.000129	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—liver cancer	4.07e-05	0.000126	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—liver cancer	3.98e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—liver cancer	3.75e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—liver cancer	3.67e-05	0.000114	CbGpPWpGaD
